153 related articles for article (PubMed ID: 10875442)
1. Initial studies with high resolution TEM and electron energy loss spectroscopy studies of ferritin cores extracted from brains of patients with progressive supranuclear palsy and Alzheimer disease.
Quintana C; Lancin M; Marhic C; Pérez M; Martin-Benito J; Avila J; Carrascosa JL
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):807-20. PubMed ID: 10875442
[TBL] [Abstract][Full Text] [Related]
2. Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin.
Quintana C; Cowley JM; Marhic C
J Struct Biol; 2004 Aug; 147(2):166-78. PubMed ID: 15193645
[TBL] [Abstract][Full Text] [Related]
3. On the structural form of iron in ferritin cores associated with progressive supranuclear palsy and Alzheimer's disease.
Dobson J
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL49-50. PubMed ID: 11936873
[TBL] [Abstract][Full Text] [Related]
4. Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.
Pérez M; Valpuesta JM; de Garcini EM; Quintana C; Arrasate M; López Carrascosa JL; Rábano A; García de Yébenes J; Avila J
Am J Pathol; 1998 Jun; 152(6):1531-9. PubMed ID: 9626057
[TBL] [Abstract][Full Text] [Related]
5. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level.
Quintana C; Bellefqih S; Laval JY; Guerquin-Kern JL; Wu TD; Avila J; Ferrer I; Arranz R; Patiño C
J Struct Biol; 2006 Jan; 153(1):42-54. PubMed ID: 16364657
[TBL] [Abstract][Full Text] [Related]
6. Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy.
Tabaton M; Whitehouse PJ; Perry G; Davies P; Autilio-Gambetti L; Gambetti P
Ann Neurol; 1988 Sep; 24(3):407-13. PubMed ID: 3067653
[TBL] [Abstract][Full Text] [Related]
7. Comparative structural and chemical studies of ferritin cores with gradual removal of their iron contents.
Gálvez N; Fernández B; Sánchez P; Cuesta R; Ceolín M; Clemente-León M; Trasobares S; López-Haro M; Calvino JJ; Stéphan O; Domínguez-Vera JM
J Am Chem Soc; 2008 Jun; 130(25):8062-8. PubMed ID: 18507465
[TBL] [Abstract][Full Text] [Related]
8. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
[TBL] [Abstract][Full Text] [Related]
9. Could a dysfunction of ferritin be a determinant factor in the aetiology of some neurodegenerative diseases?
Quintana C; Gutiérrez L
Biochim Biophys Acta; 2010 Aug; 1800(8):770-82. PubMed ID: 20447447
[TBL] [Abstract][Full Text] [Related]
10. Looking for biogenic magnetite in brain ferritin using NMR relaxometry.
Gossuin Y; Hautot D; Muller RN; Pankhurst Q; Dobson J; Morris C; Gillis P; Collingwood J
NMR Biomed; 2005 Nov; 18(7):469-72. PubMed ID: 16177954
[TBL] [Abstract][Full Text] [Related]
11. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
[TBL] [Abstract][Full Text] [Related]
12. Electron exchange between Fe(II)-horse spleen ferritin and Co(III)/Mn(III) reconstituted horse spleen and Azotobacter vinelandii ferritins.
Zhang B; Harb JN; Davis RC; Choi S; Kim JW; Miller T; Chu SH; Watt GD
Biochemistry; 2006 May; 45(18):5766-74. PubMed ID: 16669620
[TBL] [Abstract][Full Text] [Related]
13. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
[TBL] [Abstract][Full Text] [Related]
14. Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy.
Gibb GM; de Silva R; Revesz T; Lees AJ; Anderton BH; Hanger DP
Brain Res Mol Brain Res; 2004 Feb; 121(1-2):95-101. PubMed ID: 14969740
[TBL] [Abstract][Full Text] [Related]
15. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
16. The structure of ferritin cores determined by electron nanodiffraction.
Cowley JM; Janney DE; Gerkin RC; Buseck PR
J Struct Biol; 2000 Sep; 131(3):210-6. PubMed ID: 11052893
[TBL] [Abstract][Full Text] [Related]
17. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
[TBL] [Abstract][Full Text] [Related]
18. Structure of frataxin iron cores: an X-ray absorption spectroscopic study.
Nichol H; Gakh O; O'Neill HA; Pickering IJ; Isaya G; George GN
Biochemistry; 2003 May; 42(20):5971-6. PubMed ID: 12755598
[TBL] [Abstract][Full Text] [Related]
19. Image-EELS: a synthesis of energy-loss analysis and imaging.
Körtje KH
Scanning Microsc Suppl; 1994; 8():277-87;discussion 287-8. PubMed ID: 7638493
[TBL] [Abstract][Full Text] [Related]
20. Electron beam damage studies of synthetic 6-line ferrihydrite and ferritin molecule cores within a human liver biopsy.
Pan Y; Brown A; Brydson R; Warley A; Li A; Powell J
Micron; 2006; 37(5):403-11. PubMed ID: 16466926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
